Sartorius Stedim Biotech S.A.

Sector and Industry

Healthcare, Healthcare Equipment

Performance (1Y)

6.88%

Market Cap

24.50 Bil.

P/E Ratio

76.93

Dividend Yield

0.33 %

Earnings per Share

2.73 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Abbott Laboratories185.26 Bil.39.29 Bil.33.69
-53.32 %
0.00
-
Intuitive Surgical Inc171.24 Bil.8.92 Bil.71.93
+17.90 %
0.00
-
Boston Scientific Corp120.40 Bil.17.79 Bil.49.17
+49.88 %
0.00
-
Stryker Corp.114.47 Bil.22.26 Bil.41.85
+3.99 %
0.00
-
Medtronic PLC90.93 Bil.31.27 Bil.22.35
-4.61 %
0.00
-
Siemens Healthineers AG51.40 Bil.23.38 Bil.24.04
+10.40 %
0.00
-
Hoya Corp48.59 Bil.5.43 Bil.35.69
+17.33 %
0.00
-
Becton Dickinson and Co.45.46 Bil.19.79 Bil.32.18
-3.33 %
0.00
-
Edwards Lifesciences Corp42.15 Bil.5.38 Bil.47.11
-27.44 %
0.00
-
Alcon AG33.20 Bil.9.24 Bil.38.41
-7.56 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE166.5 G0 Units
PRICE DETERMINATION TIME07/21/2026 / 09:56:37 PM
DAILY VOLUME (UNITS)792
DAILY HIGH / LOW180.8160.4
PREV. DAY'S PRICE179.4 (07/20)
CHANGE DAY BEFORE
-12.90
-7.19 %
52 WEEK HIGH / LOW223.2 (01/07)150.4 (04/29)

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
3.361.812.735.076.05
DIVIDENDS PER SHARE
0.690.690.690.810.97
DIVIDEND YIELD IN %
0.29 %0.37 %0.33 %--
DIVIDEND GROWTH IN %
-52.08 %0.00 %0.00 %--
PRICE - EARNINGS RATIO
71.27104.2976.9336.6330.69
PRICE - BOOK RATIO
8.374.615.00--
PRICE - SALES RATIO
7.956.576.89--
PRICE - CASH FLOW RATIO
35.0528.6137.94--
Further Key Figures

Master Data

WKN
A2AJKS
ISIN
FR0013154002
SYMBOL
56S1
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
Sartorius Stedim Biotech
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
Euro
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Healthcare Equipment
NUMBER OF SHARES
97.32 Mil.
MARKET CAPITALISATION
24.50 Bil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-6.07 %
10.20 %
-3.86 %
-12.49 %
-6.88 %
-24.02 %
-60.03 %
-12.79 %
HIGH191.20191.20194.60211.40223.20286.30557.20223.20
LOW179.00160.80150.40150.40150.40139.80139.80150.40

Dividende

pro Aktie

Company profile

Sartorius Stedim Biotech SA provides equipment and services for the development, quality assurance, and production processes of the biopharmaceutical industry. The firm offers a broad portfolio of products that focuses on all steps in the manufacture of a biopharmaceutical, as well as in process development as prerequisite procedures. Its technologies cover inter alia, cell line technologies, cell culture media, bioreactors, and a wide range of products for separation, purification, and concentration of biological intermediates and finished products, as well as solutions for storage and transportation. It also offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production. The company was founded on September 28, 1978 and is headquartered in Aubagne, France.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.